Columbia University President Lee Bollinger announced the appointment of Anil Rustgi, MD, director of the Herbert Irving Comprehensive Cancer Center, as interim EVP and dean, effective July 1, 2020.
Scientists at Columbia's Herbert Irving Comprehensive Cancer Center are using technologies developed to study cancer to look for drugs to treat COVID-19 and disarm the virus.
In a new study of mice, Columbia researchers found that an experimental drug that breaks down an amino acid slows pancreatic tumor growth by causing ferroptosis, an unusual form of cell death.
CancerFIT—a free exercise program at CUIMC for cancer patients and survivors—offers more than a physical workout, it also provides much-needed support and inspiration.
Columbia biomedical engineers have designed a bacteria strain that seeks out solid tumors and safely delivers immunotherapies, resulting in tumor regression in mouse models.
The three scientists honored by the 2019 Horwitz Prize played key roles in identifying and deciphering the PI3K pathway, which has led to new treatments for several types of cancer.
Researchers at Columbia are tackling cancer disparities in northern Manhattan and surrounding areas through the National Cancer Institute’s network of community-based research programs.
Katherine Crew, MD, directs the Clinical Breast Cancer Prevention Program and cares for patients with breast cancer and women at high risk at Columbia University Irving Medical Center/NYP.